P300 and Genetic Risk for Schizophrenia

Article Properties
Cite
Winterer, Georg, et al. “P300 and Genetic Risk for Schizophrenia”. Archives of General Psychiatry, vol. 60, no. 11, 2003, p. 1158, https://doi.org/10.1001/archpsyc.60.11.1158.
Winterer, G., Egan, M. F., Raedler, T., Sanchez, C., Jones, D. W., Coppola, R., & Weinberger, D. R. (2003). P300 and Genetic Risk for Schizophrenia. Archives of General Psychiatry, 60(11), 1158. https://doi.org/10.1001/archpsyc.60.11.1158
Winterer, Georg, Michael F. Egan, Thomas Raedler, Carmen Sanchez, Douglas W. Jones, Richard Coppola, and Daniel R. Weinberger. “P300 and Genetic Risk for Schizophrenia”. Archives of General Psychiatry 60, no. 11 (2003): 1158. https://doi.org/10.1001/archpsyc.60.11.1158.
Winterer G, Egan MF, Raedler T, Sanchez C, Jones DW, Coppola R, et al. P300 and Genetic Risk for Schizophrenia. Archives of General Psychiatry. 2003;60(11):1158.
Citations
Title Journal Journal Categories Citations Publication Date
New portable device for an examination of visual cognitive evoked potentials might extend their diagnostic applications in psychiatry Psychiatry Research: Neuroimaging
  • Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system
  • Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry
  • Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system: Psychiatry
  • Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry
  • Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry
2024
Visual P3 abnormalities in patients with first-episode schizophrenia, unaffected siblings of schizophrenia patients and individuals at ultra-high risk for psychosis Progress in Neuro-Psychopharmacology and Biological Psychiatry
  • Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system
  • Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry
  • Medicine: Therapeutics. Pharmacology
  • Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system: Psychiatry
  • Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry
  • Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry
1 2023
Documentation of Peripheral Auditory Function in Studies of the Auditory P300 Response

Journal of Psychophysiology
  • Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry
  • Philosophy. Psychology. Religion: Psychology
  • Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry
  • Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry
1 2023
Brave New World: Harnessing the promise of biomarkers to help solve the epigenetic puzzle Schizophrenia Research
  • Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry
  • Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system: Psychiatry
  • Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system: Psychiatry
9 2022
Alternative Therapy of Psychosis: Potential Phytochemicals and Drug Targets in the Management of Schizophrenia

Frontiers in Pharmacology
  • Medicine: Therapeutics. Pharmacology
  • Medicine: Therapeutics. Pharmacology
  • Medicine: Public aspects of medicine: Toxicology. Poisons
8 2022
Citations Analysis
The category Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry 60 is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Functional and effective frontotemporal connectivity and genetic risk for schizophrenia and was published in 2003. The most recent citation comes from a 2024 study titled New portable device for an examination of visual cognitive evoked potentials might extend their diagnostic applications in psychiatry. This article reached its peak citation in 2008, with 12 citations. It has been cited in 35 different journals, 17% of which are open access. Among related journals, the Schizophrenia Research cited this research the most, with 12 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year